微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 2.91% | -38.09% | 470.59% | 32/69 | 3.11% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 0.51% | -82.53% | -94.97% | 53/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 10.14% | -12.21% | 57.7% | 18/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 6.43% | 11.63% | 36.81% | 29/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 4.7% | 6.09% | 60.96% | 25/69 | 0.66% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 2.92% | 2.1% | -74.72% | 26/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 11.55% | 25.82% | 100.52% | 16/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 5.76% | -20% | 30.02% | 43/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 4.43% | 5.48% | 54.9% | 38/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 2.86% | -2.39% | -68.85% | 34/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 9.18% | 16.78% | 27.5% | 26/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 7.2% | 4.8% | 71.43% | 33/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 4.2% | -1.18% | 43.34% | 33/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.93% | 3.53% | -62.73% | 25/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 7.86% | 29.43% | 14.42% | 31/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 6.87% | 26.52% | 61.65% | 37/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.25% | 25.74% | 50.18% | 38/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.83% | 18.41% | -53.4% | 26/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 6.07% | -42.79% | 11.85% | 40/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 5.43% | -25.1% | 60.65% | 39/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 3.38% | -28.09% | 41.42% | 35/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.39% | -17.87% | -77.49% | 25/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 10.62% | 1.87% | 46.42% | 24/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 7.25% | 5.99% | 54.26% | 36/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 4.7% | 1.51% | 61.51% | 35/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.91% | -1.02% | -72.07% | 29/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 10.42% | 32.88% | 52.34% | 31/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 6.84% | 28.33% | 47.73% | 40/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 4.63% | 22.81% | 57.48% | 34/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.94% | 26.72% | -62.51% | 29/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 7.84% | 24.08% | 47.13% | 42/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 5.33% | 9.45% | 41.38% | 48/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 3.77% | 2.17% | 62.5% | 45/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 2.32% | 0.43% | -63.29% | 34/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 6.32% | -21.88% | 29.77% | 48/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 4.87% | -18.43% | 31.98% | 43/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 3.69% | -20.3% | 59.74% | 45/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.31% | -8.33% | -71.45% | 36/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 8.09% | -23.68% | 35.51% | 43/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 5.97% | -19.32% | 28.94% | 36/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 4.63% | -8.5% | 83.73% | 36/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 2.52% | -14.29% | -76.23% | 34/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |